4,5-dihydro-3-(1-hydroxypropyl)-5-methyl-6H-imidazo[1,5-a][1,4]benzodiazepin-6-one → HCID 20515315, 화합물

HRID 67412

반응식

HRID 67412 반응식
[OH:1][CH:2]([C:5]1[N:6]=[CH:7][N:8]2[C:14]3[CH:15]=[CH:16][CH:17]=[CH:18][C:13]=3[C:12](=[O:19])[N:11]([CH3:20])[CH2:10][C:9]=12)[CH2:3][CH3:4]>[O-2].[O-2].[Mn+4].C(Cl)Cl>[CH3:20][N:11]1[C:12](=[O:19])[C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=2[N:8]2[CH:7]=[N:6][C:5]([C:2](=[O:1])[CH2:3][CH3:4])=[C:9]2[CH2:10]1

참가 물질

4

반응물 1

HCID 205153284,5-dihydro-3-(1-hydroxypropyl)-5-methyl-6H-imidazo[1,5-a][1,4]benzodiazepin-6-one

생성물 1

HCID 20515315HCID 20515315, 화합물

시약·촉매·용매 2

HCID 178418406HCID 178418406, 화합물촉매HCID 6344Dichloromethane용매

실험 절차

A mixture of 1.84 g (6.8 mmol) of 4,5-dihydro-3-(1-hydroxypropyl)-5-methyl-6H-imidazo[1,5-a][1,4]benzodiazepin-6-one, 16 g of manganese dioxide and 150 ml of methylene chloride is stirred at room temperature under an argon atmosphere for 2 hours. The manganese dioxide is filtered off under suction over a glass filter and the filtrate is evaporated in vacuo. After recrystallisation of the residue from 100 ml of ethyl acetate, there is obtained 4,5-dihydro-5-methyl-3-propionyl-6H-imidazo[1,5-a][1,4]benzodiazepin-6-one of melting point 215°-216° C.

후처리

  1. filtrationThe manganese dioxide is filtered off under suction over a glass
  2. filtrationfilter
  3. customthe filtrate is evaporated in vacuo
  4. customAfter recrystallisation of the residue from 100 ml of ethyl acetate

출처 및 근거

ORD 기록
ord-a17d29109597404a8cf1c33f2ef1bbdd
출처 데이터셋
uspto-grants-1982_08
특허 번호
US04346032

연결된 노트

불러오는 중…